Notice: Memcache::connect() [memcache.connect]: Server 192.168.72.165 (tcp 11212) failed with: Connection refused (111) in /www/sites/www.stockpickr.com/docroot/sites/all/modules/contrib/memcache/dmemcache.inc on line 250

Warning: Memcache::connect() [memcache.connect]: Can't connect to 192.168.72.165:11212, Connection refused (111) in /www/sites/www.stockpickr.com/docroot/sites/all/modules/contrib/memcache/dmemcache.inc on line 250
FOLD Stock Quote - Amicus Therapeutics Inc Stock Price and Data - Stockpickr!
Health Care: Drugs

Amicus Therapeutics Inc (FOLD: NASDAQ)

$5.61 -0.05 | -0.88%
10/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 5.61
52 Week High 7.63
52 Week Low 1.77
Avg. Daily Vol. (Mil) 2.41
Beta (3 year) 1.73
Share Related Items
Mkt Cap (Mil) 441.51
Shares Out (Mil) 78.70
Float (Mil) 33.92
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.00
Current Ratio 7.10
LT Debt/ Equity 0.36
Total Debt / Equity 0.40
Valuation Ratios
Price Earnings n.a.
Price/Sales 341.20
Price/Book 12.16
Price/Cash Flow -7.90
Per Share Data
Earnings -0.97
Sales 0.02
Book Value 0.46
Cash Flow -0.71
Business Summary
Amicus Therapeutics Inc is a biopharmaceutical company in the development stage. Its activities include raising capital, establishing facilities, and performing research and development.
General Information
1 Cedar Brook Drive
Cranbury, NJ 08512
www.amicusrx.com
Industry : Drugs
Sector: Health Care
Employees: 92
CEO: John F. Crowley
Short Interest
Current Month (Mil) 2.80
Previous Month (Mil) 3.17
Short Interest Ratio (Days) 1.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -48.60
Return on Investments -116.10
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with FOLD

Latest FOLD Headlines from TheStreet

More Financial News for FOLD

Press Releases for FOLD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter